0001165353-18-000004.txt : 20180606 0001165353-18-000004.hdr.sgml : 20180606 20180606134515 ACCESSION NUMBER: 0001165353-18-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 EFFECTIVENESS DATE: 20180606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sound Pharmaceuticals Inc CENTRAL INDEX KEY: 0001165353 IRS NUMBER: 912135919 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313998 FILM NUMBER: 18883526 BUSINESS ADDRESS: STREET 1: 4010 STONE WAY NORTH, SUITE 120 CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 206-634-2559 MAIL ADDRESS: STREET 1: 4010 STONE WAY NORTH, SUITE 120 CITY: SEATTLE STATE: WA ZIP: 98103 FORMER COMPANY: FORMER CONFORMED NAME: SOUND PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020117 D 1 primary_doc.xml X0708 D LIVE 0001165353 Sound Pharmaceuticals Inc 4010 STONE WAY NORTH, SUITE 120 SEATTLE WA WASHINGTON 98103 206-634-2559 DELAWARE SOUND PHARMACEUTICALS INC Corporation true Jonathan Kil c/o Sound Pharmaceuticals Inc 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Executive Officer Director Joseph Ashley c/o Sound Pharmaceuticals Inc 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Director Glenn Kawasaki c/o Sound Pharmaceuticals Inc 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Director David Guyer c/o Sound Pharmaceuticals Inc 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Director James C. Towne c/o Sound Pharmaceuticals Inc 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Director John Sullivan c/o Sound Pharmaceuticals Inc 4010 Stone Way N., Suite 120 Seattle WA WASHINGTON 98103 Executive Officer Biotechnology Decline to Disclose 06b false 2018-05-24 false true true Series C-2 Preferred Stock false 0 10408576 8408576 2000000 The amounts above include the conversion of note principal and interest. Actual Total Offering Amount $10,408,575.34; Actual Total Amount Sold $8,408,575.34. false 5 0 0 0 false Sound Pharmaceuticals Inc /s/ John Sullivan John Sullivan Chief Financial Officer 2018-06-06